175 related articles for article (PubMed ID: 35687267)
1. Aryl hydrocarbon receptor-kynurenine axis promotes oncogenic activity in BCP-ALL.
Wang LT; Liu KY; Wang SN; Lin MH; Liao YM; Lin PC; Huang SK; Hsu SH; Chiou SS
Cell Biol Toxicol; 2023 Aug; 39(4):1471-1487. PubMed ID: 35687267
[TBL] [Abstract][Full Text] [Related]
2. Interplay between Estrogen, Kynurenine, and AHR Pathways: An immunosuppressive axis with therapeutic potential for breast cancer treatment.
Pacheco JHL; Elizondo G
Biochem Pharmacol; 2023 Nov; 217():115804. PubMed ID: 37716620
[TBL] [Abstract][Full Text] [Related]
3. Blockade of IDO-Kynurenine-AhR Axis Ameliorated Colitis-Associated Colon Cancer via Inhibiting Immune Tolerance.
Zhang X; Liu X; Zhou W; Du Q; Yang M; Ding Y; Hu R
Cell Mol Gastroenterol Hepatol; 2021; 12(4):1179-1199. PubMed ID: 34087454
[TBL] [Abstract][Full Text] [Related]
4. Kynurenine produced by indoleamine 2,3-dioxygenase 2 exacerbates acute liver injury by carbon tetrachloride in mice.
Hoshi M; Osawa Y; Nakamoto K; Morita N; Yamamoto Y; Ando T; Tashita C; Nabeshima T; Saito K
Toxicology; 2020 May; 438():152458. PubMed ID: 32289347
[TBL] [Abstract][Full Text] [Related]
5. Indoleamine 2, 3-Dioxygenase 1 Mediates Survival Signals in Chronic Lymphocytic Leukemia
Atene CG; Fiorcari S; Mesini N; Alboni S; Martinelli S; Maccaferri M; Leonardi G; Potenza L; Luppi M; Maffei R; Marasca R
Front Immunol; 2022; 13():832263. PubMed ID: 35371054
[TBL] [Abstract][Full Text] [Related]
6. Tryptophan metabolism induced by TDO2 promotes prostatic cancer chemotherapy resistance in a AhR/c-Myc dependent manner.
Li F; Zhao Z; Zhang Z; Zhang Y; Guan W
BMC Cancer; 2021 Oct; 21(1):1112. PubMed ID: 34657603
[TBL] [Abstract][Full Text] [Related]
7. A tryptophan metabolite, kynurenine, promotes mast cell activation through aryl hydrocarbon receptor.
Kawasaki H; Chang HW; Tseng HC; Hsu SC; Yang SJ; Hung CH; Zhou Y; Huang SK
Allergy; 2014 Apr; 69(4):445-52. PubMed ID: 24397465
[TBL] [Abstract][Full Text] [Related]
8. Kynurenine Promotes RANKL-Induced Osteoclastogenesis In Vitro by Activating the Aryl Hydrocarbon Receptor Pathway.
Eisa NH; Reddy SV; Elmansi AM; Kondrikova G; Kondrikov D; Shi XM; Novince CM; Hamrick MW; McGee-Lawrence ME; Isales CM; Fulzele S; Hill WD
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114603
[TBL] [Abstract][Full Text] [Related]
9. Increased kynurenine concentration attenuates serotonergic neurotoxicity induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats through activation of aryl hydrocarbon receptor.
Abuin-Martínez C; Vidal R; Gutiérrez-López MD; Pérez-Hernández M; Giménez-Gómez P; Morales-Puerto N; O'Shea E; Colado MI
Neuropharmacology; 2021 Apr; 187():108490. PubMed ID: 33607146
[TBL] [Abstract][Full Text] [Related]
10. Indoleamine 2, 3-Dioxygenase Promotes Aryl Hydrocarbon Receptor-Dependent Differentiation Of Regulatory B Cells in Lung Cancer.
Tousif S; Wang Y; Jackson J; Hough KP; Strenkowski JG; Athar M; Thannickal VJ; McCusker RH; Ponnazhagan S; Deshane JS
Front Immunol; 2021; 12():747780. PubMed ID: 34867973
[TBL] [Abstract][Full Text] [Related]
11. Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine.
Campesato LF; Budhu S; Tchaicha J; Weng CH; Gigoux M; Cohen IJ; Redmond D; Mangarin L; Pourpe S; Liu C; Zappasodi R; Zamarin D; Cavanaugh J; Castro AC; Manfredi MG; McGovern K; Merghoub T; Wolchok JD
Nat Commun; 2020 Aug; 11(1):4011. PubMed ID: 32782249
[TBL] [Abstract][Full Text] [Related]
12. Stem cell transplantation uncovers TDO-AHR regulation of lung dendritic cells in herpesvirus-induced pathology.
Gurczynski SJ; Pereira NL; Hrycaj SM; Wilke C; Zemans RL; Moore BB
JCI Insight; 2021 Jan; 6(2):. PubMed ID: 33491663
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cell-expressed IDO alleviates atherosclerosis by expanding CD4
Wang F; Liu M; Ma D; Cai Z; Liu L; Wang J; Zhang W; Zhao L; Zhai C; Xu Y
Int Immunopharmacol; 2023 Mar; 116():109758. PubMed ID: 36706593
[TBL] [Abstract][Full Text] [Related]
14. Involvement of Aryl Hydrocarbon Receptor in L-Kynurenine-Mediated Parathyroid Hormone-Related Peptide Expression.
Duan Z; Lu J
Horm Cancer; 2019 Jun; 10(2-3):89-96. PubMed ID: 30689168
[TBL] [Abstract][Full Text] [Related]
15. Aryl hydrocarbon receptor activation-mediated vascular toxicity of ambient fine particulate matter: contribution of polycyclic aromatic hydrocarbons and osteopontin as a biomarker.
Ho CC; Wu WT; Lin YJ; Weng CY; Tsai MH; Tsai HT; Chen YC; Yet SF; Lin P
Part Fibre Toxicol; 2022 Jun; 19(1):43. PubMed ID: 35739584
[TBL] [Abstract][Full Text] [Related]
16. Orchiectomy sensitizes cortical bone in male mice to the harmful effects of kynurenine.
Bensreti H; Yu K; Alhamad DW; Shaver J; Kaiser H; Zhong R; Whichard WC; Parker E; Grater L; Faith H; Johnson M; Cooley MA; Fulzele S; Hill WD; Isales CM; Hamrick MW; McGee-Lawrence ME
Bone; 2023 Aug; 173():116811. PubMed ID: 37244427
[TBL] [Abstract][Full Text] [Related]
17. Aryl hydrocarbon receptor-mediated activity of mutagenic polycyclic aromatic hydrocarbons determined using in vitro reporter gene assay.
Machala M; Vondrácek J; Bláha L; Ciganek M; Neca JV
Mutat Res; 2001 Oct; 497(1-2):49-62. PubMed ID: 11525907
[TBL] [Abstract][Full Text] [Related]
18. Adipocyte-derived kynurenine promotes obesity and insulin resistance by activating the AhR/STAT3/IL-6 signaling.
Huang T; Song J; Gao J; Cheng J; Xie H; Zhang L; Wang YH; Gao Z; Wang Y; Wang X; He J; Liu S; Yu Q; Zhang S; Xiong F; Zhou Q; Wang CY
Nat Commun; 2022 Jun; 13(1):3489. PubMed ID: 35715443
[TBL] [Abstract][Full Text] [Related]
19. Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism.
Nguyen NT; Kimura A; Nakahama T; Chinen I; Masuda K; Nohara K; Fujii-Kuriyama Y; Kishimoto T
Proc Natl Acad Sci U S A; 2010 Nov; 107(46):19961-6. PubMed ID: 21041655
[TBL] [Abstract][Full Text] [Related]
20. Investigation of the aryl hydrocarbon receptor and the intrinsic tumoral component of the kynurenine pathway of tryptophan metabolism in primary brain tumors.
Guastella AR; Michelhaugh SK; Klinger NV; Fadel HA; Kiousis S; Ali-Fehmi R; Kupsky WJ; Juhász C; Mittal S
J Neurooncol; 2018 Sep; 139(2):239-249. PubMed ID: 29667084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
